The recent breakthrough involves a unique microrobot featuring a spherical capsule encased in a specialized gel shell. This ingenious design is manipulated using external magnetic fields, allowing for precise navigation through the bloodstream to the site of a clot. Integral to this system are iron oxide nanoparticles within the capsule, giving it the requisite magnetic properties that enable remote control. As lead author Fabian Landers notes, “The challenge lies in creating a capsule that is small enough to traverse the tiny blood vessels in the brain while still maintaining the necessary magnetic properties.”

For successful navigation, the microrobot also requires a contrast agent to enable tracking via X-ray imaging. The researchers chose tantalum nanoparticles, which pose a challenge due to their higher density and weight. This complexity necessitated a perfect interplay between materials science and robotics engineering, which ETH Professor Bradley Nelson highlights as a critical factor for success. Alongside chemist Professor Salvador Pané, the research team developed precision iron oxide nanoparticles, ensuring the microrobot operates effectively under various conditions.

Enhancing this microrobot’s functionality further, it is designed to carry medication to deliver directly to a thrombus. Researchers have successfully loaded it with commonly prescribed drugs, including those for dissolving clots, antibiotics, and anti-cancer agents. By employing a high-frequency magnetic field, the microrobot’s gel shell can be heated enough to dissolve and release its payload precisely where needed. This method promises to significantly reduce systemic side effects commonly seen with traditional drug delivery systems.

The process for deploying the microrobot involves an innovative two-step strategy. Initially, the microrobot is injected into the blood or cerebrospinal fluid through a custom-designed catheter. This catheter is based on a prevailing commercial model, which employs an internal guidewire connected to a flexible polymer gripper. Once positioned correctly, the gripper releases the microrobot, providing a straightforward yet effective means for delivering therapies directly to the target site.

Navigating through intricate blood vessels requires advanced technology, as the speed of blood flow varies considerably depending on the specific locations within the human body. To overcome these complexities, the research team developed a sophisticated electromagnetic navigation system. This system allows the microrobot to maneuver through the vascular network of the human head with remarkable accuracy, even against the forces of blood flow. The microrobot can roll along vessel walls at a controlled speed of 4 millimeters per second.

Moreover, another technique developed by researchers involves creating a magnetic field gradient. This method enables the microrobot to move toward areas of stronger magnetic fields, allowing it to swim upstream against the blood flow at impressive velocities exceeding 20 centimeters per second. The ingenious design and programming demonstrate the system’s capability to handle the significant challenges posed by the fast-moving blood within the body’s arteries.

When the microrobot encounters bifurcations in the vessels, where navigation could become problematic, in-flow navigation is employed to ensure accurate routing. In this scenario, the magnetic gradient is strategically directed along the vessel wall, guiding the microrobot into the correct pathway. The integration of these diverse navigation approaches grants the researchers a sophisticated level of control over the microrobot in a range of anatomical scenarios and flow conditions. Ultimately, a success rate exceeding 95 percent for delivering medication to the appropriate location has been achieved in trials.

To create a realistic testing environment for this microrobot technology, the researchers constructed silicone models that accurately mimic human and animal blood vessels. These models have proven so effective that they are now utilized in medical training sessions and are on offer through ETH’s spin-off, Swiss Vascular. Landers explains how essential these models have been for refining their strategy and techniques, offering a controlled environment conducive to extensive practice.

Following numerous successful trials in these silicone models, the research team transitioned to testing the microrobots in live animal subjects. Initial demonstrations successfully showcased the various navigation methods while allowing the microrobot to remain visible throughout procedures. Noteworthy achievements include guiding the microrobots through the cerebrospinal fluid of sheep, hinting at the immense potential for therapeutic applications in similar complex anatomical environments.

While the primary application of these microrobots focuses on treating thrombosis, their versatility suggests potential uses in combating localized infections or tumors. The development team has prioritized readiness for hospital use, aiming to progress into human clinical trials as soon as feasible. With each advancement, the overarching goal remains clear: to leverage technology to enhance the efficacy of medical treatments, offering new hope to patients in need.

Overall, the development of these magnetic microrobots not only marks a significant milestone in medical technology but also signifies a promising shift toward personalized and localized medical treatment strategies. As researchers continue to refine their designs and methodologies, the implications for patient care and outcomes are profound, heralding a new era of minimally invasive medical interventions. This transformative approach not only aims to improve the precision of treatments but also seeks to enhance the overall experience of patients undergoing therapeutic procedures.

With the foundation laid for clinical testing and further advancements, the research conducted at ETH Zurich stands poised to influence how medical treatments are delivered, potentially changing the trajectory of stroke treatment and beyond. The innovative design and multifaceted application of these microrobots highlight the brilliant intersections of robotics, materials science, and medicine, with the ultimate aim of saving lives and improving health outcomes.

This innovative methodology illustrates a shift not only in the technical capabilities of such systems but also emphasizes the ongoing commitment of researchers to create accessible and effective therapies. As the research progresses towards human trials, the excitement surrounding the potential real-world applications of this technology grows, promising to redefine the landscape of targeted drug delivery for years to come.

Through their dedicated pursuit of knowledge and practical application, the team at ETH Zurich exemplifies the spirit of innovation necessary to tackle some of the most pressing health challenges facing society today. Their pioneering work serves as a testament to the power of interdisciplinary collaboration, ultimately paving the way for future advancements in medical technology and therapeutic interventions that prioritize patient well-being.

In conclusion, the successful development of these microrobots offers a glimpse into the future of targeted therapy, demonstrating the remarkable potential of robotics in medicine. As the team plans to advance into clinical trials, the hope remains that these advanced delivery systems will not only transform the treatment of strokes but also broaden the horizons of medical science, paving the way for an era defined by precision medicine.

Subject of Research: Development of magnetic microrobots for targeted drug delivery in stroke treatment.
Article Title: Clinically ready magnetic microrobots for targeted therapies.
News Publication Date: 13-Nov-2025
Web References: DOI
References: Landers F, Hertle L, Pustovalov V et al.: Clinically ready magnetic microrobots for targeted therapies. Science (2025), DOI:10.1126/science.adx1708
Image Credits: (Luca Donati / lad.studio Zurich)

Keywords

Magnetic microrobots, targeted therapies, stroke treatment, drug delivery, medical technology, ETH Zurich, nanoparticles, electromagnetic navigation, minimally invasive procedures.

Understanding chirality is essential because molecules that are nearly identical in composition can behave drastically differently based on their three-dimensional orientation. This phenomenon is evident in daily life — for instance, caraway seeds and spearmint contain molecules with nearly identical structures but emit very different aromas because they are mirror images, or enantiomers, of each other. Similarly, many pharmaceuticals owe their efficacy to this molecular asymmetry, as one enantiomer of a drug molecule may be therapeutic while its mirror image is ineffective or even toxic. Until now, studying these variations at a detailed, localized scale has posed a formidable challenge.

The team’s novel technique leverages the interaction between chiral samples and circularly polarized light to generate a spatial map of handedness within a sample. Circular polarization refers to light waves whose electric field vectors rotate in a spiral as the light propagates, either clockwise or counterclockwise. Chiral molecules and nanostructures interact differently with these two types of circularly polarized light, absorbing or rotating the light’s oscillations in distinct ways depending on their handedness. Capitalizing on these optical signatures, the researchers developed a single-shot wide-field spectroscopic imaging method to spatially resolve chirality.

What sets this approach apart from traditional methods is its ability to capture both left- and right-circularly polarized light interactions simultaneously in one image, rather than requiring separate measurements for each polarization state. To accomplish this, the team crafted a sophisticated optical system that splits the light transmitted through the sample into its circularly polarized components by employing carefully engineered reference beams. These beams create interference patterns that encode how the sample differentially interacts with left- and right-handed circular polarizations. While these overlapping patterns are incomprehensible to the naked eye, computational algorithms decode the data to produce clear, color-coded maps of the chiral distribution across the sample surface.

In a laboratory demonstration, the researchers applied their imaging technology to artificial nanostructures fabricated from gold, which were deliberately designed with varying handedness. The experiment validated the method’s ability to accurately distinguish left-handed from right-handed regions, visualizing intricate shapes such as letters “L” and “R” composed of nanoscale chiral elements. This ability to spatially resolve chirality at the nanoscale is a marked improvement over existing techniques, which only yield average information and cannot reveal heterogeneity in the sample’s handedness.

The implications of this breakthrough extend well beyond physics and nanotechnology, offering transformative potential for diverse fields such as biology, medicine, and materials science. Biological tissues and cells often exhibit chirality not only at the molecular level but also in larger structural arrangements. However, characterizing these spatial variations without damaging the sample or relying on chemical staining has been an elusive goal. The imaging method pioneered by Quidant’s group could offer a non-invasive way to detect and map chirality differences between healthy and diseased tissues, potentially leading to novel diagnostic tools.

In the realm of material engineering, many advanced materials display spatially varied chirality, which influences their optical, mechanical, and chemical properties. Until now, this spatial variation has been difficult to assess directly. The new technique provides researchers with a powerful tool to visualize handedness patterns within complex materials, enabling deeper insight into how chirality affects macroscopic behavior and facilitating the design of new materials with tailored chiral features.

Pharmaceutical sciences stand to benefit significantly from this technology as well. Since many drugs are chiral, with only one enantiomer providing the desired therapeutic effect, being able to map the chirality distribution within complex mixtures or formulations can improve drug design, quality control, and analytical procedures. This imaging approach may enable chemists and pharmacologists to identify chiral impurities or quantify enantiomeric excess with spatial specificity, thereby refining drug safety and efficacy.

Despite its promise, the technique remains at an early stage of development. One of the main challenges the team has faced is the intrinsic weakness and noise sensitivity of the optical signals associated with chirality at the nanoscale. To ensure that the measured signals genuinely stem from chiral interactions rather than artefacts, the researchers implemented meticulous noise-reduction strategies and signal processing protocols. Future work will focus on enhancing the system’s sensitivity and robustness to enable practical applications outside the laboratory environment.

Moving forward, the researchers are keen to collaborate with experts across various disciplines to explore potential use cases and optimize the system for real-world scenarios. As lead author Rebecca Büchner notes, while the platform’s capabilities are well understood by the team, other scientists might identify novel applications and tailor the technology to address domain-specific questions. Whether in clinical diagnostics, material characterization, or pharmaceutical analysis, the ability to map chirality spatially with a single image heralds a new era of chiral research.

Ultimately, this pioneering work illustrates the power of merging advanced optics, nanotechnology, and computational imaging to solve longstanding scientific challenges. By making the invisible spatial patterns of molecular handedness visible, it opens the door to a deeper understanding of chiral phenomena that underpin chemistry, biology, and materials science. The pathway from this fundamental research to transformative applications may be long, but the potential impact on science and technology is immense.

This research was recently published in the prestigious journal Nature Photonics, highlighting the interdisciplinary collaboration and technical ingenuity underpinning the advance. With continued development and collaboration, spatially resolved chirality imaging could soon become a staple in laboratories worldwide, enriching our ability to see and study the asymmetrical world at the heart of matter.

Subject of Research: Imaging and visualization of molecular and nanoscale chirality through wide-field spectroscopic methods.

Article Title: Wide-field spectroscopic imaging of optical activity

News Publication Date: 28-Jul-2025

Web References: https://doi.org/10.1038/s41566-025-01722-0

Keywords: chirality, handedness, circularly polarized light, nanophotonics, optical activity, nanostructures, spectroscopy, spatial imaging, molecular asymmetry, drug efficacy, biomedical imaging

Professor Jürg Leuthold, a respected figure in the field of photonics and communications, has consistently pushed the boundaries of what is possible with optical technologies. With the advent of the next generation of mobile communications, notably 6G, which is expected to operate in the terahertz range, the need for efficient data transfer methods has never been more pressing. Optical fibers serve as the backbone for these future communications, and the introduction of highly efficient modulators is set to enhance the seamless transmission of data. As Professor Leuthold aptly notes, "Data is always initially present in electrical form, and nowadays, its transmission always involves optical fibers at some point." This fundamental understanding underpins the critical role that modulators will play in the evolution of communications technology.

The significance of this advancement extends beyond telecommunications; it presents a myriad of applications across various fields. Researchers have indicated that these modulators could be utilized in high-performance computing centers where massive data volumes are exchanged. In addition, the versatility of this technology offers potential applications in medical imaging, spectroscopy for material analysis, scanning technology in airports, and radar systems. With such diverse implications, it is clear that this cutting-edge modulator is not only a breakthrough in theoretical physics but will also serve as an essential tool in practical applications.

Central to this new modulator’s capabilities is its remarkable design, a sophisticated nanostructure that incorporates various materials, prominently featuring gold. The interaction between light and free electrons in the gold allows for the high-frequency modulation needed to transmit information at unprecedented speeds. This interaction is crucial as it enables the direct transfer of terahertz signals onto optical fibers without the need for cumbersome intermediary components. As a result, this new device not only enhances transmission speeds but also reduces energy consumption, a key concern in modern technology.

While existing methods of transferring terahertz signals onto optical fibers are technically feasible, they necessitate multiple expensive and complex systems to achieve effective signal conversion. The ETH Zurich team’s innovative approach culminates in a single component capable of operating across a broad frequency range—from 10 megahertz to an impressive 1.14 terahertz. By achieving this broad operational spectrum with one device, researchers emphasize the convenience and efficiency of their development, eliminating the need for various components tailored to specific frequency ranges.

The direct application of this modulator could also find its way into various sectors of measurement technology. For instance, the healthcare industry could greatly benefit from enhanced medical imaging techniques, where high-resolution and high-speed data are essential for accurate diagnostics. Furthermore, the precision offered by this modulator may facilitate better material analysis through spectroscopic methods, expanding the possibilities within scientific research and industrial applications.

The potential use of these modulators is indeed vast. High-performance measurement technology, including imaging methods for medicine or high-speed optical data transfers in computational centers, will particularly benefit from this innovation. The ability to transmit large volumes of data at terahertz frequencies may lead to significant improvements in the operational efficiency of critical infrastructures, thus enhancing service delivery across numerous disciplines.

As the ETH Zurich research team, led by Ph.D. candidate Yannik Horst, aims to transition this technology from research to a commercial product, Polariton Technologies—a company that emerged from Leuthold’s group—plays a pivotal role in this journey towards market readiness. The ambition is clear: to enable the widespread adoption of this terahertz modulator for various applications in data transmission and measurement technology. Plans are already in motion to bring this innovation to market, leveraging its groundbreaking advantages to address the insatiable demand for faster and more efficient communication systems.

In summary, the development of the plasmonic modulator heralds a new era of communication technology capable of harnessing terahertz signals for improved data transmission. This innovation speaks to the broader trends challenging existing paradigms in how we approach data communication and processing. As the world continues to evolve towards increasingly interconnected systems, the profound impact of such technological advancements will be felt across diverse fields, ensuring that the future is not only faster but also far more efficient in managing the deluge of data that defines our digital age.

As industries gear up to embrace these new capabilities, the implications for enhanced connectivity and intelligence in data processing cannot be overstated. Indeed, this new modulator stands as a testament to the remarkable progress being made and serves as a pivotal development in the ongoing exploration of photonics and communications technologies. Researchers around the globe will undoubtedly watch with keen interest as this promising technology transitions from the lab to real-world applications, transforming the landscape of telecommunications and beyond.

Subject of Research: Plasmonic modulators for terahertz signal transmission
Article Title: Breakthrough in Plasmonic Modulators: Enabling Terahertz Data Transmission
News Publication Date: Upcoming in 2025
Web References: Optica Journal
References: Horst Y, Moor D, Chelladurai D, Blatter T, Fernandes S, Kulmer L, Baumann M, Ibili H, Funck C, Keller K, Destraz M, Heni W, Chérix L, Liu Y, Wang H, Koepfli SM, Leuthold J: Ultra-Wideband MHz to THz Plasmonic EO Modulator. Optica 2025, 12: 325
Image Credits: ETH Zurich, Polariton Technologies

Keywords

Plasmonic modulators, terahertz communication, optical fibers, data transmission, photonics, ETH Zurich, Jürg Leuthold, wireless technology, energy efficiency, medical imaging.